Literature DB >> 20807046

MicroRNAs in benign and malignant hematopoiesis.

Sharathkumar Bhagavathi1, Magdalena Czader.   

Abstract

MicroRNAs (miRNAs) are a family of 19- to 24-nucleotide noncoding RNAs that regulate messenger RNA function at the posttranscriptional and translational level. Recent literature demonstrates a significant role of miRNAs in normal and malignant hematopoiesis. Specific miRNAs have been shown to regulate each step of hematopoiesis starting at the level of multipotent progenitors through terminal stages of myeloid and lymphoid differentiation. Similarly, individual miRNAs and miRNA signatures have been associated with specific hematologic malignancies. There is accumulating evidence that miRNAs can be used for diagnostic, prognostic, and therapeutic purposes. This review highlights the current status of knowledge on miRNA in normal and malignant hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807046     DOI: 10.5858/2009-0178-RS.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

Review 1.  MicroRNA-146a and hemopoietic disorders.

Authors:  Zhong Hua; Wang Chun; Chen Fang-Yuan
Journal:  Int J Hematol       Date:  2011-09-08       Impact factor: 2.490

2.  Expression of small nucleolar RNAs in leukemic cells.

Authors:  Kaisa J Teittinen; Asta Laiho; Annemari Uusimäki; Juha-Pekka Pursiheimo; Attila Gyenesei; Olli Lohi
Journal:  Cell Oncol (Dordr)       Date:  2012-11-15       Impact factor: 6.730

3.  Genomic conservation of erythropoietic microRNAs (erythromiRs) in white-blooded Antarctic icefish.

Authors:  Thomas Desvignes; H William Detrich; John H Postlethwait
Journal:  Mar Genomics       Date:  2016-05-14       Impact factor: 1.710

4.  Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding.

Authors:  Viviana Caputo; Lorenzo Sinibaldi; Alessia Fiorentino; Chiara Parisi; Caterina Catalanotto; Augusto Pasini; Carlo Cogoni; Antonio Pizzuti
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

5.  Co-expression Pattern Analysis of miR-17-92 Target Genes in Chronic Myelogenous Leukemia.

Authors:  Fengfeng Wang; Fei Meng; Lili Wang
Journal:  Front Genet       Date:  2016-09-21       Impact factor: 4.599

Review 6.  The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy.

Authors:  Chengxin Luan; Zixue Yang; Baoan Chen
Journal:  Onco Targets Ther       Date:  2015-10-13       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.